cyc 202 has been researched along with Kidney, Polycystic in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 7 (63.64) | 29.6817 |
| 2010's | 4 (36.36) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alkanderi, S; Filby, A; Henry, C; Miles, CG; Molinari, E; Ramsbottom, SA; Saunier, S; Sayer, JA; Srivastava, S; White, K | 1 |
| Billot, K; Boletta, A; Bukanov, N; Coquil, C; Delehouzé, C; Desban, N; Fautrel, A; Fischer, E; Grosch, M; Ibraghimov-Beskrovnaya, O; Josselin-Foll, B; Le Meur, Y; Meijer, L; Mrug, M; Oumata, N; Pontoglio, M; Saunier, S; Tran, PV; Trudel, M; Villiers, B; Wallace, D; Weimbs, T; Witzgall, R | 1 |
| Deen, PM; Devuyst, O; Di Mise, A; Lasorsa, D; Mastrofrancesco, L; Mola, MG; Ranieri, M; Svelto, M; Tamma, G; Trimpert, C; Valenti, G | 1 |
| Beier, DR; Billot, K; Bukanov, NO; Carlson, G; Husson, H; Ibraghimov-Beskrovnaya, O; Lane, M; Ledbetter, SR; Meijer, L; Moreno, S; Pitstick, R; Russo, RJ; Sergeev, M; Shah, J; Smith, LA; Smith, MM; Zhang, K | 1 |
| Bukanov, NO; Ibraghimov-Beskrovnaya, O; Moreno, S | 1 |
| Beales, PL; Tobin, JL | 1 |
| Chowdhury, R; Igarashi, P; Patel, V | 1 |
| Bukanov, NO; Ibraghimov-Beskrovnaya, O; Klinger, KW; Ledbetter, SR; Smith, LA | 1 |
| Ibraghimov-Beskrovnaya, O | 1 |
| Kuehn, EW; Walz, G | 1 |
| Bukanov, NO; Dackowski, WR; Gareski, TC; Husson, H; Ibraghimov-Beskrovnaya, O; Matthews, D; Natoli, TA; Piepenhagen, P; Russo, RJ; Smith, L | 1 |
3 review(s) available for cyc 202 and Kidney, Polycystic
| Article | Year |
|---|---|
Advances in the pathogenesis and treatment of polycystic kidney disease.
Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Cell Polarity; Cilia; Humans; Kinesins; Octreotide; Polycystic Kidney Diseases; Purines; Roscovitine; Sirolimus; TRPP Cation Channels | 2009 |
Targeting dysregulated cell cycle and apoptosis for polycystic kidney disease therapy.
Topics: Animals; Apoptosis; Cell Cycle Proteins; Cell Differentiation; Cell Proliferation; Cyclin-Dependent Kinases; Enzyme Inhibitors; Genes, cdc; Humans; Mice; Polycystic Kidney Diseases; Purines; Roscovitine | 2007 |
Prime time for polycystic kidney disease: does one shot of roscovitine bring the cure?
Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Clinical Trials as Topic; Disease Models, Animal; Genes, Dominant; Humans; Mice; Models, Biological; Polycystic Kidney Diseases; Protein Kinase Inhibitors; Protein Kinases; Purines; Roscovitine; TOR Serine-Threonine Kinases | 2007 |
8 other study(ies) available for cyc 202 and Kidney, Polycystic
| Article | Year |
|---|---|
A human patient-derived cellular model of Joubert syndrome reveals ciliary defects which can be rescued with targeted therapies.
Topics: Abnormalities, Multiple; Antigens, Neoplasm; Cell Cycle Proteins; Cerebellum; Child; Child, Preschool; Cilia; Ciliopathies; Cyclin-Dependent Kinase 5; Cytoskeletal Proteins; Epithelial Cells; Eye Abnormalities; Humans; Kidney Diseases, Cystic; Kidney Failure, Chronic; Male; Morpholines; Mutation; Neoplasm Proteins; Pedigree; Polycystic Kidney Diseases; Primary Cell Culture; Purines; Retina; Roscovitine; Signal Transduction | 2017 |
Casein kinase 1ε and 1α as novel players in polycystic kidney disease and mechanistic targets for (R)-roscovitine and (S)-CR8.
Topics: Animals; Casein Kinase 1 epsilon; Casein Kinase Ialpha; Catalysis; Chromatography, Affinity; Disease Models, Animal; Humans; Kidney; Mice, Transgenic; Polycystic Kidney Diseases; Protein Binding; Protein Kinase Inhibitors; Purines; Pyridines; Roscovitine; Signal Transduction | 2018 |
A protein kinase A-independent pathway controlling aquaporin 2 trafficking as a possible cause for the syndrome of inappropriate antidiuresis associated with polycystic kidney disease 1 haploinsufficiency.
Topics: Animals; Aquaporin 2; Calcium Signaling; Cyclic AMP-Dependent Protein Kinases; Cyclin-Dependent Kinases; Haploinsufficiency; In Vitro Techniques; Male; Mice; Polycystic Kidney Diseases; Protein Phosphatase 2; Purines; Rats, Sprague-Dawley; Roscovitine; Vasopressins | 2014 |
Reduction of ciliary length through pharmacologic or genetic inhibition of CDK5 attenuates polycystic kidney disease in a model of nephronophthisis.
Topics: Animals; Cell Differentiation; Cilia; Cyclin-Dependent Kinase 5; Disease Models, Animal; Humans; Intercellular Signaling Peptides and Proteins; Kidney; Kidney Failure, Chronic; Mice; Nerve Tissue Proteins; Polycystic Kidney Diseases; Purines; Roscovitine; Tubulin | 2016 |
Serum and urinary biomarker signatures for rapid preclinical in vivo assessment of CDK inhibition as a therapeutic approach for PKD.
Topics: Animals; Biomarkers; Blood Proteins; Cyclin-Dependent Kinases; Disease Models, Animal; Mice; Mice, Inbred C57BL; Polycystic Kidney Diseases; Protein Kinase Inhibitors; Proteins; Purines; Roscovitine; Treatment Outcome | 2008 |
Restoration of renal function in zebrafish models of ciliopathies.
Topics: Animals; Antineoplastic Agents; Bardet-Biedl Syndrome; Cilia; Disease Models, Animal; Immunosuppressive Agents; Kidney; Polycystic Kidney Diseases; Purines; Recovery of Function; Roscovitine; Sirolimus; Zebrafish | 2008 |
Long-lasting arrest of murine polycystic kidney disease with CDK inhibitor roscovitine.
Topics: Animals; Apoptosis; Cyclin-Dependent Kinases; Disease Models, Animal; Disease Progression; Kidney; Mice; Mice, Inbred C57BL; Mice, Mutant Strains; Polycystic Kidney Diseases; Purines; Roscovitine; Time Factors | 2006 |
Pkd1 and Nek8 mutations affect cell-cell adhesion and cilia in cysts formed in kidney organ cultures.
Topics: Alleles; Animals; Cadherins; Cell Adhesion; Cilia; Cyclin-Dependent Kinases; Cysts; Disease Models, Animal; Female; Male; Mice; Mice, Knockout; Mutation; NIMA-Related Kinases; Organ Culture Techniques; Polycystic Kidney Diseases; Protein Kinase Inhibitors; Protein Kinases; Protein Serine-Threonine Kinases; Purines; Roscovitine; TRPP Cation Channels | 2008 |